HELLP syndrome is a severe obstetric emergency defined by the triad of Hemolysis, Elevated Liver enzymes, and Low Platelets. It is a complication of the preeclampsia–eclampsia spectrum, not a standalone disease and not a diagnostic mnemonic. HELLP occurs in roughly 10–20% of patients with severe preeclampsia and carries a maternal mortality of 1–3% when severe, with fetal/perinatal loss ranging from 7–20% depending on gestational age and class.
For labor and delivery nurses, HELLP is a condition where pattern recognition saves lives. Right upper quadrant pain in a third-trimester patient, a platelet drop on a routine CBC, or a postpartum woman with flu-like symptoms 36 hours after delivery can each be the first clue. This reference covers the pathophysiology, diagnostic criteria (Mississippi and Tennessee classifications), nursing priorities, magnesium sulfate management, complications, and NCLEX high-yield points every nursing student should know.
What HELLP syndrome is (and is not)
HELLP syndrome is a variant of severe preeclampsia characterized by microangiopathic hemolytic anemia, hepatocellular injury, and thrombocytopenia. It was first described by Louis Weinstein in 1982 and has since been classified by Martin et al. (Mississippi) and Sibai (Tennessee).
Common misconceptions to dismantle before you sit for NCLEX:
- HELLP is not “postpartum preeclampsia.” About 70% of cases present antepartum, typically between 27 and 37 weeks’ gestation. The remaining ~30% develop within 48 hours after delivery, with a peak around 24–48 hours postpartum.
- HELLP is not a diagnostic mnemonic nurses use to identify preeclampsia. It is a clinical diagnosis defined by specific laboratory criteria applied to a patient with signs of preeclampsia.
- HELLP can occur without hypertension or proteinuria. Up to 15–20% of patients present normotensive, and proteinuria may be absent in up to 20%. A normal blood pressure does not exclude HELLP.
Pathophysiology in one paragraph
The underlying process is endothelial dysfunction — the same vascular pathology that drives preeclampsia. Placental ischemia triggers release of anti-angiogenic factors (sFlt-1, soluble endoglin) that damage maternal endothelium. The damaged vessel walls activate platelets, consume them, and shear red blood cells as they pass through fibrin-lined capillaries. This produces the three hallmarks: hemolysis (schistocytes, elevated LDH, low haptoglobin), hepatocyte injury from sinusoidal fibrin deposition (elevated AST/ALT, RUQ pain from Glisson’s capsule stretch), and thrombocytopenia from consumption.
Diagnostic criteria
Two classifications are in common use. The Mississippi Classification (Martin et al.) is more widely cited in contemporary literature because it stratifies severity by platelet count, which correlates with maternal morbidity.
| Parameter | Mississippi Class 1 (severe) | Mississippi Class 2 (moderate) | Mississippi Class 3 (mild) | Tennessee (complete) |
|---|---|---|---|---|
| Platelets | <50,000/µL | 50,000–100,000/µL | 100,000–150,000/µL | <100,000/µL |
| AST or ALT | ≥70 IU/L | ≥70 IU/L | ≥40 IU/L | >70 IU/L |
| LDH | ≥600 IU/L | ≥600 IU/L | ≥600 IU/L | >600 IU/L |
| Maternal morbidity | Highest (DIC ~15%, mortality up to 6%) | Intermediate | Lowest | Defined as all three present |
Partial HELLP (Tennessee incomplete) refers to patients meeting one or two criteria but not all three — still clinically significant and managed similarly to severe preeclampsia.
Supporting laboratory findings
- Peripheral blood smear: schistocytes (fragmented red cells) confirm microangiopathic hemolytic anemia — the “H” in HELLP
- Haptoglobin: low (<25 mg/dL) due to binding to free hemoglobin
- Total bilirubin: ≥1.2 mg/dL (indirect predominant)
- Fibrinogen: normal initially; falling fibrinogen signals evolving DIC
- Uric acid: often elevated (>5.9 mg/dL), correlates with severity
- Creatinine: rises with renal involvement
For a broader review of laboratory thresholds used in maternal care, see our nursing lab values cheat sheet.
Clinical presentation
Symptoms are nonspecific and frequently mistaken for gastroenteritis, viral illness, or gallbladder disease. Approximately 90% of patients report RUQ or epigastric pain, which is the most reliable red flag in a pregnant or recently postpartum patient.
| Symptom or sign | Frequency | Nursing note |
|---|---|---|
| RUQ or epigastric pain | ~90% | From stretching of Glisson’s capsule over an edematous liver; do not confuse with GERD |
| Nausea and vomiting | 30–80% | Often worsens over hours, not days |
| Malaise / flu-like symptoms | 90% | Classic presentation in postpartum HELLP — do not reassure |
| Headache | 30–60% | May indicate central nervous system involvement |
| Visual disturbance | ~20% | Scotomata, blurred vision |
| Hypertension (≥140/90) | 80–85% | Up to 15–20% are normotensive at presentation |
| Proteinuria | ~80% | Absent in ~20% of cases |
| Edema (especially facial) | Common | Nonspecific in pregnancy |
| Jaundice | Rare | Late finding, concerning for hepatic dysfunction |
Key teaching point: a third-trimester patient reporting “I just don’t feel right” with a tender RUQ and a platelet count that dropped from 230,000 last week to 130,000 today has HELLP until proven otherwise.
Nursing assessment and priorities
HELLP management is time-critical. The nurse is the first line of surveillance — serial vitals, labs, fetal tracing, and deep tendon reflex checks detect deterioration before catastrophe.
| Priority | Assessment | Intervention |
|---|---|---|
| 1. Maternal stability | BP q15 min until stable, then q30–60 min; HR, RR, SpO2; pain score; DTRs; urine output (target >30 mL/hr) | Two large-bore IVs (18-gauge or larger); continuous cardiac monitoring if severe; type and screen (type and cross if platelets <50,000) |
| 2. Fetal surveillance | Continuous EFM; biophysical profile if <34 weeks; note decelerations, loss of variability | Left lateral position; oxygen 10 L/min via non-rebreather if non-reassuring tracing; notify provider immediately |
| 3. Seizure prophylaxis | Assess for headache, visual changes, clonus, hyperreflexia | Magnesium sulfate 4–6 g IV loading dose over 15–20 min, then 2 g/hr maintenance infusion |
| 4. Blood pressure control | Sustained BP ≥160 systolic or ≥110 diastolic (over 15 min) = severe range | IV labetalol 20 mg (may escalate to 40, then 80 mg), hydralazine 5–10 mg IV, or oral nifedipine 10 mg per protocol |
| 5. Fetal lung maturation | Gestational age <34 weeks | Betamethasone 12 mg IM q24h x 2 doses; optimal benefit at 48 hours but delivery should not be delayed in Class 1 HELLP for steroid completion if maternal status deteriorates |
| 6. Coagulation monitoring | CBC, PT/INR, PTT, fibrinogen q6–12h; monitor for DIC (oozing from IV sites, petechiae, hematuria) | Platelet transfusion if <20,000/µL (or <50,000/µL before cesarean); FFP and cryoprecipitate if fibrinogen <100 mg/dL |
| 7. Delivery planning | Gestational age, cervical exam, fetal status, maternal trajectory | Definitive treatment is delivery. Vaginal delivery preferred if Bishop favorable and maternal status permits; cesarean for obstetric indications or rapidly deteriorating mother |
Magnesium sulfate — the detail that shows up on NCLEX
Magnesium sulfate is given for seizure prophylaxis in severe preeclampsia and HELLP. The therapeutic range is 4–7 mEq/L (4.8–8.4 mg/dL).
Toxicity progresses in a predictable order, and DTRs are lost before respiratory depression — this is why every MgSO4 assessment includes reflexes:
- Loss of patellar reflex: 8–12 mg/dL (first sign)
- Respiratory depression (RR <12): 12–15 mg/dL
- Cardiac arrest: >25 mg/dL
Antidote: calcium gluconate 1 g IV over 3 minutes. Stop the magnesium infusion first, then administer calcium gluconate.
Nursing monitoring during MgSO4:
- DTRs every hour (patellar if no epidural; biceps or triceps if spinal or epidural anesthesia blunts leg reflexes)
- Respiratory rate every hour (hold infusion if RR <12)
- Urine output every hour (hold if <30 mL/hr for 2 consecutive hours — magnesium is renally excreted)
- Magnesium level q4–6h in at-risk patients (renal impairment)
- Continuous fetal monitoring — magnesium decreases FHR variability, which is expected and not a sign of distress
For a broader review of electrolyte pharmacology, including magnesium, see our electrolyte imbalances nursing reference.
Complications
HELLP carries a high complication rate. Every nurse working a high-acuity OB unit should recognize these before they declare themselves.
- Disseminated intravascular coagulation (DIC): most feared complication, reported in 15–20% of Class 1 HELLP. Fibrinogen below 300 mg/dL in late pregnancy (when it should be 400–600) is an early warning. Watch for oozing from IV sites, gum bleeding, petechiae, and hematuria.
- Placental abruption: occurs in approximately 16% of HELLP cases. Sudden abdominal pain, vaginal bleeding (may be concealed), uterine tetany, and fetal distress. See our placenta previa and abruption nursing reference for full assessment patterns.
- Acute kidney injury: rising creatinine, oliguria. Usually reversible with delivery and supportive care.
- Pulmonary edema: more common postpartum as fluid mobilizes. Dyspnea, rales, falling SpO2. Strict fluid balance is essential — total IV intake is generally limited to 80–125 mL/hr.
- Hepatic hematoma or rupture: rare (<1%) but catastrophic. Presents with sudden severe RUQ or epigastric pain, referred shoulder pain (Kehr’s sign), hypotension, and tachycardia. Immediate imaging (FAST ultrasound or CT) and surgical consultation. Mortality can exceed 50%.
- Stroke and eclamptic seizures: CNS involvement from vasospasm, edema, or hemorrhage.
- Postpartum hemorrhage: thrombocytopenia increases bleeding risk. See our postpartum hemorrhage nursing reference.
- Maternal mortality: 1–3% in severe cases; higher in Class 1 or when complicated by DIC, hepatic rupture, or stroke.
HELLP vs preeclampsia vs eclampsia
Students frequently confuse these three entities. The table below clarifies where HELLP sits on the preeclampsia spectrum.
| Feature | Preeclampsia | Eclampsia | HELLP |
|---|---|---|---|
| Onset | >20 weeks gestation; may extend to 6 weeks postpartum | During pregnancy, labor, or postpartum | ~70% antepartum (27–37 wks); ~30% within 48h postpartum |
| Blood pressure | ≥140/90 (two readings, 4h apart) or ≥160/110 (severe) | Typically elevated but seizure is defining feature | Elevated in 80–85%; normotensive in 15–20% |
| Proteinuria | ≥300 mg/24h or P:Cr ratio ≥0.3 (required unless severe features) | Usually present | Absent in ~20% |
| Laboratory changes | Normal or mildly abnormal; severe features include platelets <100k, AST/ALT 2x normal, creatinine >1.1 | Same as severe preeclampsia | Defined by lab triad (hemolysis, AST/ALT ≥70, platelets <100k or <150k per classification) |
| Seizure | No seizure (if seizure occurs, diagnosis becomes eclampsia) | Generalized tonic-clonic seizure — defining feature | Possible (HELLP + eclampsia); seizure prophylaxis with MgSO4 is standard |
| Definitive treatment | Delivery; timing depends on severity and gestational age | Stabilize, control seizures, deliver | Delivery; immediate if Class 1, gestation ≥34 weeks, or maternal/fetal deterioration |
| Magnesium sulfate | Indicated for severe features | Indicated (load, then maintenance) | Indicated |
For a full review of preeclampsia assessment and management, see the preeclampsia nursing reference. For the broader picture of third-trimester complications, the obstetric nursing reference covers related conditions.
Delivery planning
Delivery is the only definitive treatment for HELLP syndrome. The decision framework is grounded in the ACOG Practice Bulletin 222 (2020) on gestational hypertension and preeclampsia, and echoed in Sibai’s landmark 2004 review.
- Gestational age ≥34 weeks: deliver promptly after maternal stabilization
- Gestational age 24–34 weeks with stable mother and fetus: administer corticosteroids (betamethasone), consider expectant management for 24–48 hours under maternal-fetal medicine supervision, then deliver
- Gestational age <24 weeks or maternal deterioration at any age: deliver regardless — maternal survival takes precedence
- Class 1 HELLP, DIC, abruption, non-reassuring fetal status, hepatic rupture, stroke, or renal failure: immediate delivery
Route of delivery: vaginal delivery is preferred if cervical exam is favorable and maternal status permits. Cesarean is indicated for obstetric reasons, rapidly deteriorating maternal status, or non-reassuring fetal heart tracing. Platelet transfusion before cesarean is generally recommended if count is <50,000/μL.
NCLEX high-yield points
These are the points item writers love. Memorize them.
- RUQ or epigastric pain in a pregnant patient with hypertension equals HELLP until proven otherwise. Do not attribute it to GERD, gastritis, or gallbladder disease without a CBC, LFTs, and LDH.
- HELLP can occur without hypertension or proteinuria. A normal BP does not exclude the diagnosis. Up to 15–20% are normotensive at presentation.
- The lab triad: LDH ≥600 IU/L, AST or ALT ≥70 IU/L, platelets <100,000/μL (Tennessee complete) or the Mississippi Class thresholds.
- Schistocytes on peripheral smear indicate microangiopathic hemolytic anemia and confirm the “H” in HELLP. Low haptoglobin and elevated indirect bilirubin support the finding.
- Magnesium sulfate monitoring: DTRs are lost before respiratory depression. Check patellar reflex with every assessment. RR <12, urine output <30 mL/hr, or absent DTRs means hold the infusion and notify the provider. The antidote is calcium gluconate 1 g IV.
- Definitive treatment is delivery. Class 1 HELLP, gestation ≥34 weeks, or maternal/fetal deterioration = deliver regardless of gestational age. Expectant management is only for stable mother/fetus under MFM supervision.
- Betamethasone before 34 weeks for fetal lung maturity (12 mg IM q24h x 2 doses). Do not delay delivery beyond 48 hours solely to complete steroid course if maternal status deteriorates.
- Postpartum HELLP is real. It peaks 24–48 hours after delivery and can occur up to 7 days out. Do not dismiss a postpartum patient presenting with RUQ pain, malaise, and flu-like symptoms — draw a CBC and LFTs.
- Hepatic rupture is a surgical emergency. Sudden severe RUQ pain with hemodynamic instability in a HELLP patient — call the surgical team, activate massive transfusion protocol, and prepare for laparotomy.
- DIC risk rises as platelets fall. Monitor fibrinogen (falling is bad — it should be 400–600 in late pregnancy), PT/INR, and clinical signs of bleeding (oozing IV sites, petechiae, hematuria). Class 1 HELLP has a DIC rate of 15–20%.
Recurrence and counseling
Women with a history of HELLP have an elevated risk of recurrent HELLP (approximately 3–5%) and a higher risk of preeclampsia in subsequent pregnancies (15–25%). Preconception counseling, early prenatal care, and consideration of low-dose aspirin (81 mg daily starting at 12–16 weeks) for preeclampsia prevention are appropriate per ACOG guidance.
Clinical sources referenced
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology. 2020;135(6):e237–e260.
- Martin JN Jr, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification. American Journal of Obstetrics and Gynecology. 1999;180(6 Pt 1):1373–1384.
- Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstetrics & Gynecology. 2004;103(5 Pt 1):981–991.
- Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy and Childbirth. 2009;9:8.
- StatPearls. HELLP Syndrome. National Library of Medicine, 2023.
Related references
- Preeclampsia nursing reference
- Obstetric nursing reference hub
- Postpartum hemorrhage nursing
- Placenta previa and abruption nursing
- Nursing lab values cheat sheet
- Electrolyte imbalances nursing reference
- BUBBLE HE postpartum assessment
- VEAL CHOP fetal heart rate patterns
This article is for educational purposes and NCLEX preparation. It does not substitute for clinical training, facility protocols, or direct provider orders.